Loading insider details...
Latest Form 4 (May 21, 2026): Grant/Award of 10,539 PASG shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Passage BIO, Inc. (PASG) | Grant/Award | 10,539 | n/a |
| May 30, 2025 | Passage BIO, Inc. (PASG) | Grant/Award | 143,789 | n/a |
| Mar 5, 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 18,443 | n/a |
| Oct 2, 2024 | Passage BIO, Inc. (PASG) | Grant/Award | 174,139 | n/a |
| Mar 12, 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 11,509 | $574.6K |
| Mar 6, 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 17,800 | n/a |
| Oct 24, 2023 | Ultragenyx Pharmaceutical Inc. (RARE) | Exercise/Conversion | 39,878 | $273.6K |
| Mar 4, 2023 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 2,663 | n/a |
| Mar 15, 2022 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 10,281 | $688.9K |
| Mar 3, 2022 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 2,374 | $158.2K |